Chris Mason is an award-winning geneticist and associate professor at Weill Cornell Medicine, as well as director of the WorldQuant Initiative for Quantitative Prediction. His NYC-based laboratory explores a wide diversity of research topics, from cancer genetics to microbe diversity in subway systems to the comparative DNA and RNA of working astronauts. The author of over 150 scientific publications, Dr. Mason was named one of the Brilliant Ten by Popular Science and his work has been featured in the New York Times, Wall Street Journal, Time, and National Geographic and on PBS, CNN, and beyond. He has co-founded four biotechnology start-up companies and serves as an advisor to many others.